724
Views
6
CrossRef citations to date
0
Altmetric
Letter to the Editor

Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?

Pages 793-795 | Published online: 12 Aug 2013

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.